BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS
The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also inc...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BRANDISH, Phil DUFORT, Fay UHLENBROICH, Sandra MCDONNELL, Kevin REPASH, Liz KEEN, Nicholas GAYNOR, Katie CHEN, Liuhong MUDD, Gemma LEITHEISER, Chris |
description | The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022206394A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022206394A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022206394A13</originalsourceid><addsrcrecordid>eNrjZNBz8nSOdPbxdFYIcA0I8XRxVfDxdHf0cwlWCA5wdfZ0A0q4-Qcp-HkrOLv6-ATzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4x1AjAyMjIwMzY0sTR0Nj4lQBAE5XJik</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><source>esp@cenet</source><creator>BRANDISH, Phil ; DUFORT, Fay ; UHLENBROICH, Sandra ; MCDONNELL, Kevin ; REPASH, Liz ; KEEN, Nicholas ; GAYNOR, Katie ; CHEN, Liuhong ; MUDD, Gemma ; LEITHEISER, Chris</creator><creatorcontrib>BRANDISH, Phil ; DUFORT, Fay ; UHLENBROICH, Sandra ; MCDONNELL, Kevin ; REPASH, Liz ; KEEN, Nicholas ; GAYNOR, Katie ; CHEN, Liuhong ; MUDD, Gemma ; LEITHEISER, Chris</creatorcontrib><description>The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=AU&NR=2022206394A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=AU&NR=2022206394A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BRANDISH, Phil</creatorcontrib><creatorcontrib>DUFORT, Fay</creatorcontrib><creatorcontrib>UHLENBROICH, Sandra</creatorcontrib><creatorcontrib>MCDONNELL, Kevin</creatorcontrib><creatorcontrib>REPASH, Liz</creatorcontrib><creatorcontrib>KEEN, Nicholas</creatorcontrib><creatorcontrib>GAYNOR, Katie</creatorcontrib><creatorcontrib>CHEN, Liuhong</creatorcontrib><creatorcontrib>MUDD, Gemma</creatorcontrib><creatorcontrib>LEITHEISER, Chris</creatorcontrib><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><description>The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz8nSOdPbxdFYIcA0I8XRxVfDxdHf0cwlWCA5wdfZ0A0q4-Qcp-HkrOLv6-ATzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4x1AjAyMjIwMzY0sTR0Nj4lQBAE5XJik</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>BRANDISH, Phil</creator><creator>DUFORT, Fay</creator><creator>UHLENBROICH, Sandra</creator><creator>MCDONNELL, Kevin</creator><creator>REPASH, Liz</creator><creator>KEEN, Nicholas</creator><creator>GAYNOR, Katie</creator><creator>CHEN, Liuhong</creator><creator>MUDD, Gemma</creator><creator>LEITHEISER, Chris</creator><scope>EVB</scope></search><sort><creationdate>20230824</creationdate><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><author>BRANDISH, Phil ; DUFORT, Fay ; UHLENBROICH, Sandra ; MCDONNELL, Kevin ; REPASH, Liz ; KEEN, Nicholas ; GAYNOR, Katie ; CHEN, Liuhong ; MUDD, Gemma ; LEITHEISER, Chris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022206394A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BRANDISH, Phil</creatorcontrib><creatorcontrib>DUFORT, Fay</creatorcontrib><creatorcontrib>UHLENBROICH, Sandra</creatorcontrib><creatorcontrib>MCDONNELL, Kevin</creatorcontrib><creatorcontrib>REPASH, Liz</creatorcontrib><creatorcontrib>KEEN, Nicholas</creatorcontrib><creatorcontrib>GAYNOR, Katie</creatorcontrib><creatorcontrib>CHEN, Liuhong</creatorcontrib><creatorcontrib>MUDD, Gemma</creatorcontrib><creatorcontrib>LEITHEISER, Chris</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BRANDISH, Phil</au><au>DUFORT, Fay</au><au>UHLENBROICH, Sandra</au><au>MCDONNELL, Kevin</au><au>REPASH, Liz</au><au>KEEN, Nicholas</au><au>GAYNOR, Katie</au><au>CHEN, Liuhong</au><au>MUDD, Gemma</au><au>LEITHEISER, Chris</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><date>2023-08-24</date><risdate>2023</risdate><abstract>The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2022206394A1 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T15%3A02%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BRANDISH,%20Phil&rft.date=2023-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022206394A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |